The Latest
-
White House seeks 12% cut to HHS in 2027
The Trump administration is requesting about $111 billion in discretionary funding for the HHS, nearly $16 billion less than its budget in 2026.
-
Scientists urge EPA not to weaken ethylene oxide emissions standards
Scientists, clinicians and residents of communities near medical device sterilization plants called for the EPA not to weaken its oversight of ethylene oxide in a public hearing.
-
Restore Robotics cleared to remanufacture 2 more da Vinci Xi instruments
The remanufacturer said it now has a total of four clearances for Intuitive Surgical da Vinci instruments from the Food and Drug Administration.
-
Trump adjusts tariffs for steel, aluminum, copper
Goods made entirely of the metals will still face a 50% tariff, but the levy will be reduced to 25% for certain derivative goods, effective April 6.
-
Merit Medical acquires View Point for $140M
View Point sells tumor tissue localization devices that could complement Merit’s existing presence in the sector.
-
J&J’s Impella heart pump shows no patient benefit in 2 trials
Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat heart attack patients who don’t have cardiogenic shock.
-
Distalmotion targets ASC robotic gynecology programs with FDA filing
The company is seeking clearance in additional gynecological indications to support outpatient use of its surgical robot.
-
Medtronic to study renal denervation combined with PCI
Medtronic detailed plans to further study the blood pressure treatment while releasing additional data from the SPYRAL HTN trials that showed the procedure reduced hypertensive emergencies.
-
Whoop raises $575M, adds Abbott as strategic investor
Whoop, the maker of a wearable wristband, plans to use the funds for global expansion and personalized health features.
-
Medtronic wins CE mark for OmniaSecure defibrillation lead
The device maker designed the lead to have the safety benefits of small-diameter devices without sacrificing durability.
-
Boston Scientific posts positive stroke prevention data for Watchman
The company said it will seek an expanded indication for the left atrial appendage closure device after it met all safety and efficacy goals in the closely watched CHAMPION-AF study.
-
Medtronic wins FDA clearance for robot in cranial, ENT surgeries
The surgical navigation and robotics system is part of the company’s push to expand its share of the $15 billion cranial and spinal technologies market.
-
Glucotrack plans US trial of implantable glucose monitor this year
Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the second half of 2026.